Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

ASCENDIS PHARMA A/S

(A14M6X)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über ASCENDIS PHARMA A/S
21.10.ASCENDIS PHARMA A/S : Notice to convene Extraordinary General Meeting - Form 6-K
17.10.Certain Ordinary Shares of Ascendis Pharma A/S are subject to a Lock-Up Agreement Endin..
17.10.Certain Warrants of Ascendis Pharma A/S are subject to a Lock-Up Agreement Ending on 1..
15.10.U.S. Supreme Court refuses stay request for Spire Missouri natgas pipe
15.10.Health Care Stocks Climb Pre-Bell Friday
15.10.ASCENDIS PHARMA A/S : Health Care
15.10.ASCENDIS PHARMA A/S : INCORPORATION BY REFERENCE - Form 6-K
15.10.ASCENDIS PHARMA A/S : Begins US Commercial Launch of Pediatric Growth Hormone Deficiency T..
15.10.ASCENDIS PHARMA A/S : Announces U.S. Commercial Launch of SKYTROFA® (Lonapegsomatropin-tcg..
15.10.Ascendis Pharma A/S Announces U.S. Commercial Launch of Skytrofa the First and Only FDA..
06.10.European ADRs Move Lower in Wednesday Trading
01.10.ASCENDIS PHARMA A/S : Articles of Association (Form 6-K)
30.09.ASCENDIS PHARMA A/S : A/S Announces Presentations for TransCon™ PTH and TransCon&tra..
30.09.Ascendis Pharma A/S Announces Presentations for TransCon PTH and TransCon CNP at the Am..
29.09.ASCENDIS PHARMA A/S : to Buy Back Up to $25 Million in American Depositary Shares by Year-..
29.09.ASCENDIS PHARMA A/S : Announces Share Repurchase Program
29.09.Ascendis Pharma A/S announces an Equity Buyback for 300,000 shares, for $25 million.
29.09.Ascendis Pharma A/S authorizes a Buyback Plan.
27.09.PRIME MINING : Appoints New Board Member and Exploration Executive, Provides Update
23.09.European ADRs Move Sharply Higher in Thursday Trading
22.09.ASCENDIS PHARMA A/S : INCORPORATION BY REFERENCE (Form 6-K)
22.09.Ascendis Pharma A/S Announces Mean Bone Mineral Density (BMD) Data from Phase 2 PaTH Fo..
22.09.Ascendis Pharma A/S Announces Mean Bone Mineral Density Data from Phase 2 PaTH Forward ..
16.09.ASCENDIS PHARMA A/S : Articles of Association (Form 6-K)
07.09.ASCENDIS PHARMA A/S : Seeks FDA Nod to Start TransCon Trial in Patients with Advanced Canc..
07.09.Ascendis Pharma A/S Announces Upcoming Investor Presentations
07.09.Ascendis Pharma A/S Submits Investigational New Drug Application to Initiate TransCon&t..
07.09.Ascendis Pharma A/S Submits Investigational New Drug Application to Initiate TransCon™ ..
07.09.European ADRs Move Lower in Tuesday Trading
02.09.European ADRs Move Higher in Thursday Trading
02.09.ASCENDIS PHARMA A/S : Prices Offering at $160 Per ADS
02.09.Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
01.09.Health Care Stocks Reverse Losses as Biotechs Rise
01.09.ADRs End Mostly Higher, Ascendis Pharma Trades Actively
01.09.Health Care Stocks Edging Lower, Biotechs Working to Limit Declines
01.09.Health Care Stocks Inch Higher Ahead of Wednesday Open
31.08.ASCENDIS PHARMA A/S : Launches Share Offering -- Stock Down 4% After-Hours
31.08.Ascendis Pharma A/S Announces Proposed Public Offering of ADSs
27.08.ASCENDIS PHARMA A/S : Unaudited Condensed Consolidated Interim Statements of Profit or Los..
27.08.European ADRs Rise Nearly 1% Friday Morning
27.08.ASCENDIS PHARMA A/S : INCORPORATION BY REFERENCE (Form 6-K)
27.08.ASCENDIS PHARMA A/S : Reports Second Quarter 2021 Financial Results (Form 6-K)
26.08.AFTER HOURS WATCH LIST SCORECARD : Asnd, zuo, slqt,
26.08.SECTOR UPDATE : Health Care Stocks Ending Slightly Lower This Afternoon
26.08.SECTOR UPDATE : Health Care Stocks Pare Early Declines
26.08.Ascendis Pharma Shares Up About 25% After FDA Approval of Skytrofa
26.08.European ADRs Move Lower in Thursday Trading
26.08.Wall Street Treads Water Pre-Bell, Q2 GDP Growth Upwardly Revised to 6.6%
26.08.SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Thursday
26.08.US Futures Quiet Ahead of GDP Data
26.08.UPDATE : Ascendis Pharma Q2 Loss Widens as Sales Drop; Shares Rise Pre-Market on FDA Nod f..
25.08.MT NEWSWIRES AFTER HOURS WATCH LIST : Asnd, zuo, slqt
25.08.ASCENDIS PHARMA A/S : Q2 Loss Widens, Revenue Declines; Wins FDA Approval for Growth Hormo..
25.08.ASCENDIS PHARMA A/S : Q2 Earnings and Skytrofa® FDA Approval Call
25.08.Ascendis Pharma A/S Reports Second Quarter 2021 Financial Results
25.08.Ascendis Pharma A/S Reports Earnings Results for the Second Quarter Ended June 30, 2021
25.08.Ascendis Pharma A/S Announces U.S. Food and Drug Administration Approval of SKYTROFA® (..
25.08.Ascendis Pharma Announces U.S. Food and Drug Administration Approval of SKYTROFA
25.08.ASCENDIS PHARMA : FDA Approves Skytrofa to Treat Pediatric Growth Hormone Deficiency
25.08.ASCENDIS PHARMA A/S : Trading in Ascendis Pharma Shares Halted Pending News Release
17.08.Ascendis Pharma A/S Announces Second Quarter 2021 Financial Results and Business Update..
12.08.ASCENDIS PHARMA A/S : Articles of Association (Form 6-K)
06.08.ASCENDIS PHARMA A/S : Announces Upcoming Investor Presentations in August
03.08.European ADRs Move Higher in Tuesday Trading
16.07.PAYCOM SOFTWARE : Insider Selling in Paycom Software (PAYC) Shares Continues
15.07.ASCENDIS PHARMA A/S : Articles of Association (Form 6-K)
14.07.INSIDER TRENDS : Insider 90-Day Selling Trend Prolonged at Paycom Software
06.07.ASCENDIS PHARMA A/S : Hits Target Enrollment Target for Phase Trial of TransCon PTH
06.07.ASCENDIS PHARMA A/S : INCORPORATION BY REFERENCE (Form 6-K)
06.07.ASCENDIS PHARMA A/S : Announces Target Enrollment Achieved in the Phase 3 PaTHway Trial of..
06.07.Ascendis Pharma A/S Announces Target Enrollment Achieved in the Phase 3 PaTHway Trial o..
29.06.European ADRs Move Lower in Tuesday Trading
14.06.European ADRs Move Higher in Monday Trading
14.06.Ascendis Pharma A/S Appoints Birgitte Volck as the Senior Vice President & Head of Clin..
14.06.Ascendis Pharma A/S Announces U.S. Food and Drug Administration Notifies Information Su..
1  2  3  4  5  6Weiter
Anstehende Termine für ASCENDIS PHARMA A/S